REPLIGEN CORPORATION - COMMON STOCK

Repligen Reports Second Quarter 2024 Financial Results

30 يوليو 2024 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

29 يوليو 2024 13:00:00 بحسب Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2024 Financial Results

16 يوليو 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Announces CEO Transition Plan

13 يونيو 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming June Investor Conferences

22 مايو 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming May Investor Conferences

07 مايو 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports First Quarter 2024 Financial Results

01 مايو 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen to Report First Quarter 2024 Financial Results

17 أبريل 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Appoints Maggie A. Pax to Board of Directors

19 مارس 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2023 Financial Results

21 فبراير 2024 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2023 Financial Results

07 فبراير 2024 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

19 ديسمبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements

07 ديسمبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire

UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report

14 نوفمبر 2023 11:01:50 بحسب Nasdaq GlobeNewswire

Repligen Announces Publication of the Company’s 2022 Sustainability Report

14 نوفمبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

07 نوفمبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device

02 نوفمبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

31 أكتوبر 2023 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report Third Quarter 2023 Financial Results

17 أكتوبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

02 أكتوبر 2023 04:30:00 بحسب Nasdaq GlobeNewswire